Aesthetic Medical International Holdings Group Ltd.

Good morning, ladies and gentlemen. Thanks for standing by and welcome to Aesthetic Medical International first quarter 2021 earnings conference call. During today's presentation, all parties will be in a listen-only mode. As a reminder, today's conference call is being recorded. On the call today from Aesthetic Medical International are Dr. Peng Wu-Zhou, Chairman and Chief Executive Officer, and Mr. Toby Wu, Chief Financial Officer. Dr. Joe will review the business operations and the company highlights, followed by Mr. Wu, who will discuss financials performance. There will be a Q&A session that follows. Before we get started, I'd like to remind you that some of the information discussed will include forward business statements regarding future events and our future financial performance. These include statements about our future expectations, financial projections, and our plans and prospects. Actual results may differ materially from those set forth in such statements. For discussion of these risks and uncertainties, you should review the company's findings with the SEC, which includes today's press release. You should not rely on our forward-looking statements as predictions of future events. All forward-looking statements that we make on this call are based on assumptions and beliefs as of today, and we undertake no obligation to update them except as required by applicable law. Our discussion today will include non-IFRS financial measures, including EBITDA, adjusted profit, and adjusted EBITDA. You should not consider EBITDA, adjusted EBITDA, and adjusted profit as a substitute for or superior to net income prepared in accordance with IFRS. Furthermore, because non-IFRS measures are not determined In accordance with IFRS, they are susceptible to varying calculations and may not be comparable to other similarly titled measures presented by other companies. You are encouraged to review the company's financial information in its entirety and not rely on a single financial measure. At this time, I would like to turn the call over to Dr. Peng Wu Zhou, Chairman and CEO of Aesthetic Medical International. Dr. Zhou, please go ahead.

Thank you, host. Thank you, everyone, for attending today's meeting. We have just announced that our company's strong financial and financial performance in the first quarter of 2021 will increase by 131.4% in terms of revenue, and will recover from the economic downturn in China since the COVID-19 pandemic. Thank you, operator, and everyone for joining the call today.

We are pleased to announce that we recorded a strong financial and operating result in the first quarter of 2021, with revenue increased 131.4% year-on-year. thanks to the economic recovery of China from the COVID-19 pandemic and our dedicated team members who seized every opportunity to help us weather the storm.